Roche buys rights to Oryzon's cancer-suppressing gene drug
ZURICH (Reuters) - Roche has bought the rights to an experimental drug from Spain's Oryzon Genomics that can switch on genes to block cancer growth, a...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/2rALrwdax88/story01.htm
No comments:
Post a Comment